Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Royce & Associates LP

Royce & Associates LP trimmed its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 3.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,626 shares of the company’s stock after selling 298 shares during the quarter. Royce & Associates LP’s holdings in Addus HomeCare were worth $1,081,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Natixis Advisors LLC grew its holdings in shares of Addus HomeCare by 4.8% in the third quarter. Natixis Advisors LLC now owns 38,561 shares of the company’s stock valued at $5,130,000 after purchasing an additional 1,777 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Addus HomeCare in the 3rd quarter valued at approximately $1,622,000. Intech Investment Management LLC grew its stake in shares of Addus HomeCare by 137.1% in the third quarter. Intech Investment Management LLC now owns 5,008 shares of the company’s stock worth $666,000 after acquiring an additional 2,896 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Addus HomeCare by 8.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 227,209 shares of the company’s stock worth $30,226,000 after acquiring an additional 18,555 shares during the period. Finally, Alpha DNA Investment Management LLC acquired a new stake in shares of Addus HomeCare in the third quarter valued at $392,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on ADUS. Stephens reissued an “overweight” rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie reissued an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Oppenheimer boosted their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $89.83 on Friday. The firm’s fifty day moving average price is $111.83 and its 200 day moving average price is $121.87. Addus HomeCare Co. has a 12 month low of $87.88 and a 12 month high of $136.72. The company has a market capitalization of $1.63 billion, a price-to-earnings ratio of 20.56, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. As a group, sell-side analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.